177 related articles for article (PubMed ID: 33672682)
1. Formyl Peptide Receptor 2 Alleviates Hepatic Fibrosis in Liver Cirrhosis by Vascular Remodeling.
Jun JH; Park SY; Park S; Park HJ; Kim JY; Park GT; Bae SH; Kim JH; Kim GJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672682
[TBL] [Abstract][Full Text] [Related]
2. Combination Therapy of Placenta-Derived Mesenchymal Stem Cells with WKYMVm Promotes Hepatic Function in a Rat Model with Hepatic Disease via Vascular Remodeling.
Jun JH; Park S; Kim JY; Lim JY; Park GT; Kim JH; Kim GJ
Cells; 2022 Jan; 11(2):. PubMed ID: 35053347
[TBL] [Abstract][Full Text] [Related]
3. The Salvia miltiorrhiza monomer IH764-3 induces apoptosis of hepatic stellate cells in vivo in a bile duct ligation-induced model of liver fibrosis.
Liu L; Wei J; Huo X; Fang S; Yao D; Gao J; Jiang H; Zhang X
Mol Med Rep; 2012 Dec; 6(6):1231-8. PubMed ID: 22971838
[TBL] [Abstract][Full Text] [Related]
4. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
5. Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cells.
Chen YH; Lan T; Li J; Qiu CH; Wu T; Gou HJ; Lu MQ
World J Gastroenterol; 2012 Dec; 18(48):7158-65. PubMed ID: 23326120
[TBL] [Abstract][Full Text] [Related]
6. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.
Patsenker E; Popov Y; Stickel F; Schneider V; Ledermann M; Sägesser H; Niedobitek G; Goodman SL; Schuppan D
Hepatology; 2009 Nov; 50(5):1501-11. PubMed ID: 19725105
[TBL] [Abstract][Full Text] [Related]
8. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
9. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
10. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
[TBL] [Abstract][Full Text] [Related]
11. TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition.
Kim MJ; Park SA; Kim CH; Park SY; Kim JS; Kim DK; Nam JS; Sheen YY
Cell Physiol Biochem; 2016; 38(2):571-88. PubMed ID: 26845171
[TBL] [Abstract][Full Text] [Related]
12. A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells.
Park KC; Park JH; Jeon JY; Kim SY; Kim JM; Lim CY; Lee TH; Kim HK; Lee HG; Kim SM; Kwon HJ; Suh JS; Kim SW; Choi SH
Br J Pharmacol; 2014 Nov; 171(21):4820-30. PubMed ID: 24467283
[TBL] [Abstract][Full Text] [Related]
13. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
Tang LX; He RH; Yang G; Tan JJ; Zhou L; Meng XM; Huang XR; Lan HY
PLoS One; 2012; 7(2):e31350. PubMed ID: 22363627
[TBL] [Abstract][Full Text] [Related]
14. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
[TBL] [Abstract][Full Text] [Related]
15. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation.
Lu ZN; Niu WX; Zhang N; Ge MX; Bao YY; Ren Y; Guo XL; He HW
Acta Pharmacol Sin; 2021 Nov; 42(11):1808-1820. PubMed ID: 34465912
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.
Liu Y; Wang Z; Kwong SQ; Lui ELH; Friedman SL; Li FR; Lam RWC; Zhang GC; Zhang H; Ye T
J Hepatol; 2011 Sep; 55(3):612-625. PubMed ID: 21251937
[TBL] [Abstract][Full Text] [Related]
18. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
Li Y; Lua I; French SW; Asahina K
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
[TBL] [Abstract][Full Text] [Related]
19. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]